年間契約型情報サービス

Gastrointesinal Drugs News:胃腸薬関連ニュースサービス

Gastrointestinal Drug News

発行 Espicom Business Intelligence 商品コード 66834
出版日 年間契約型情報サービス ページ情報 英文
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
Gastrointesinal Drugs News:胃腸薬関連ニュースサービス Gastrointestinal Drug News
出版日: 年間契約型情報サービス ページ情報: 英文
概要

当ニューズレターでは、Espicom社のリサーチャーおよびエディターが企業・研究機関、カンファレンスなどから収集した胃腸薬関連の最新ニュースをオンラインにてお届けいたします。

提供内容

  • 全タイプの胃腸薬とその開発動向などに関する最新ニュースの全文
  • 最新情報を入手しやすく、扱いやすいインターフェース
  • 2,120以上の記事を含む広範なアーカイブ
  • 迅速で高効率の検索機能
  • デイリー&ウィークリーEメールアラート
  • RSSフィード機能
目次

Abstract

These days we all suffer from information overload. To overcome this problem, the Gastrointestinal Drug News service focuses specifically on GI drugs, delivering the information you need in a timely, flexible and convenient format.

Long gone are the days when the GI market was dominated by H2 antagonists and PPIs with the focus very much on conditions of the upper GI tract. The treatment of GORD continues to be a growth market, but now growing clinical awareness and improving rates of diagnosis are seeing conditions such as IBD (ulcerative colitis, Crohn' s disease) and IBS take centre stage in future plans - indeed, many feel that the potential patient population for these conditions is only now beginning to be recognised.

For pharmaceutical company executives, researchers and commercial managers, this sector is taking an important role in the industry' s plans; staying in touch with the latest twists and turns, however, is another matter. That is why this new, daily-updated online information service is essential.

The Gastrointesinal Drugs News information service provides:

  • The full text of the latest news reported on all types of GI drugs and their development
  • An easy-to-use interface that immediately takes you to the most recently updated information
  • An extensive archive of over 2,120 articles which makes the service a valuable tracking and research tool
  • A fast and effective search facility allowing you to identify information relevant to you
  • Daily or weekly email alerts which will ensure you know when new information is added
  • An RSS feed facility

Every day, Espicom' s researchers and editors

  • Track the companies and research organisations that are shaping the industry
  • Report the latest developments in current and up coming GI drugs
  • Monitor results from major conferences and meetings
Back to Top